Global Preclinical Imaging Market is Expected to Reach a Value of USD 675.00 Million in 2016

Preclinical Imaging Market is forecast to grow at a CAGR of 6.5% for the forecast period of 2017 to 2024 to an estimated value of USD 675.00 million in 2016 with factors such as the stringent regulations governing preclinical research along with momentous installation and operational costs coupled with preclinical imaging modalities which are hindering the growth of the market.

Moreover, the increasing emerging markets and technological advancement of in-vivo imaging will further boost various new opportunities that will fuel the growth of the preclinical imaging market in the above mentioned forecast period.

Preclinical Imaging Market Scenario

According to Data Bridge Market Research, the preclinical imaging market in developing regions is witnessing a growth in terms of its adoption rate, rising amount of public-private initiatives and increasing research & development activities. Increasing technological progressions is also anticipated to enhance the growth of preclinical imaging market in the forecast period of 2017 to 2024.

Now the question is which are the regions that preclinical imaging market players should target? Data Bridge Market Research has forecast North America to dominate the preclinical imaging market.

For more analysis on the preclinical imaging market, request for a briefing with our analysts

Preclinical Imaging Market Development

  • In June 2018, MILabs had launched the E-Class line of preclinical tomographic imaging products, featured with the high-performance, SPECT, economical PET, optical and CT systems specially designed for researchers with a limited budget. This launch has helped the company to enhance its product portfolio.

Preclinical Imaging Market Scope

Preclinical imaging  market is segmented on the basis of countries into the U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Israel, Egypt, South Africa, Rest of Middle East and Africa.

  • All country based analysis of the preclinical imaging market is further analyzed based on maximum granularity into further segmentation. On the basis of modality, the preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-ultrasound, photoacoustic imaging systems, micro-MRI, micro-CT, magnetic particle imaging (MPI) systems, and photoacoustic imaging systems. On the basis of product, the preclinical imaging market is segmented into computed tomography (CT) imaging, medical devices, magnetic resonance imaging (MRI) imaging, positron emission tomography/ single photon emission computed tomography (PET/SPECT) imaging, multi-modal imaging, optical imaging, and ultrasound imaging. On the basis of application, the preclinical imaging market is segmented into research & development, and drug discovery. On the basis of end-user, the preclinical imaging market is segmented into pharmaceutical companies, research institutes, and biotech companies.
  • Preclinical imaging is mainly used in live animal research for drug advancement and is also used to scrutinize the treatment response for early signs of efficiency. The technological development of in vivo imaging proffers an opportunity for evaluation disease at the molecular level in a quantitative way.

To know more about the study

Key Pointers Covered in the Preclinical Imaging Market Industry Trends and Forecast to 2024

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Agilent Technologies
  • MILabs B.V.
  • Aspect Imaging
  • Trifoil Imaging
  • Siemens Healthcare Private Limited
  • Fujifilm Holdings Corporation
  • Bruker
  • MR Solutions
  • Capintec
  • Berthold Technologies
  • INDEC BioSystems
  • Hitachi Medical
  • LI-COR Biosciences
  • Mediso Medical Imaging Systems
  • Angstrom Advanced Inc
  • Kubtec X-Ray
  • Miltenyi Biotec GMBH
  • Naviscan
  • PerkinElmer
  • Thermo Fisher Scientific Inc.

Above are the key players covered in the report, to know about more and exhaustive list of preclinical imaging companies’, contact us

Research Methodology of Global Preclinical Imaging Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecast using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global Vs Regional Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@